LEMAITRE VASCULAR INC (LMAT)
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Instruments & Supplies
LeMaitre Vascular, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 6, 2026 | 81.98 | 82.59 | 79.93 | 80.89 | 326,444 |
| Nov 5, 2026 | 81.79 | 85.97 | 80.73 | 83.49 | 533,948 |
| Nov 4, 2026 | 82.44 | 89.23 | 81.95 | 87.92 | 520,423 |
| Nov 3, 2026 | 81.26 | 82.12 | 80.47 | 80.60 | 425,316 |
| Nov 2, 2026 | 82.06 | 82.39 | 80.80 | 81.26 | 270,730 |
| Oct 30, 2026 | 85.53 | 85.53 | 80.03 | 80.94 | 427,367 |
| Oct 29, 2026 | 83.87 | 85.65 | 83.16 | 85.27 | 300,113 |
| Oct 28, 2026 | 83.38 | 84.54 | 82.49 | 82.87 | 360,739 |
| Oct 27, 2026 | 84.56 | 84.70 | 83.56 | 83.79 | 221,961 |
| Oct 26, 2026 | 84.41 | 85.81 | 84.00 | 84.31 | 270,609 |
| Oct 23, 2026 | 85.00 | 85.37 | 83.94 | 84.45 | 184,575 |
| Oct 22, 2026 | 84.06 | 85.63 | 83.20 | 85.33 | 212,772 |
| Oct 21, 2026 | 82.71 | 84.04 | 81.93 | 83.67 | 216,661 |
| Oct 20, 2026 | 83.16 | 83.90 | 82.84 | 83.40 | 238,026 |
| Oct 19, 2026 | 81.02 | 82.73 | 80.74 | 82.31 | 248,748 |
| Oct 16, 2026 | 82.53 | 84.24 | 80.69 | 80.82 | 311,556 |
| Oct 15, 2026 | 83.82 | 84.66 | 82.86 | 83.16 | 297,901 |
| Oct 14, 2026 | 81.26 | 82.92 | 80.81 | 82.62 | 316,035 |
| Oct 13, 2026 | 83.64 | 83.85 | 81.29 | 81.55 | 247,758 |
| Oct 12, 2026 | 80.77 | 83.25 | 80.03 | 82.91 | 257,857 |
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| President and Director | Grant/Award | 2.126 | -- | Sep 3, 2026 | |
| Director | Grant/Award | 0.543 | -- | Sep 3, 2026 | |
| President and Director | Grant/Award | 4.352 | -- | Sep 3, 2026 | |
| Director | Grant/Award | 1.664 | -- | Sep 3, 2026 | |
| Chairman and CEO | Grant/Award | 4.673 | -- | Sep 3, 2026 | |
| Chairman and CEO | Grant/Award | 19.587 | -- | Sep 3, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
BlackRock, Inc. | 3.3M | 14.3% | 13F |
BlackRock, Inc. · also on 13F· may incl. warrants· filed Apr 2025 | 3.1M | 13.6% | 13G |
Conestoga Capital Advisors · also on 13F· may incl. warrants· filed Jan 2026 | 1.5M | 6.7% | 13G |
George W. LeMaitre · may incl. warrants· filed May 2026 | 1.5M | 6.4% | 13G |
FIRST TRUST ADVISORS LP | 1.1M | 4.8% | 13F |
Copeland Capital Management · also on 13F· may incl. warrants· filed Jan 2025 | 989.0K | 4.3% | 13G |
CONGRESS ASSET MANAGEMENT CO | 961.5K | 4.2% | 13F |
VANGUARD CAPITAL MANAGEMENT LLC | 953.4K | 4.2% | 13F |
Copeland Capital Management, LLC | 924.1K | 4.0% | 13F |
STATE STREET CORP | 901.4K | 3.9% | 13F |
Insiders
- Roberts David BPresident and Director
- SHADAN MARTHADirector
- Pellegrino Joseph P JRDirector
- LeMaitre George WChairman and CEO
- Roush John ADirector
- Jasinski Lawrence JDirector
- O'Connor John JamesDirector
- Kamke Trent GSenior V. P., Operations
- LeBlanc Dorian PaulChief Financial Officer
- Ross Bridget ADirector
Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease.
Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi.
The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque. Another offering is radiopaque tape, a medical-grade adhesive applied externally to help interventionists precisely cross-reference skin locations with underlying anatomical features like vessels or lesions. Further products include valvulotomes, instruments used to cut or disrupt valves within the saphenous vein, enabling it to function as an arterial bypass to carry blood past diseased arteries to the lower leg or foot.
Additionally, LeMaitre supplies vascular grafts for bypassing or replacing compromised arteries. Moreover, the company provides vascular and cardiac patches for post-surgical vessel closure.
Its closure systems employ titanium clips for connecting vessels, offering an alternative to traditional sutures. Products are distributed via both its direct sales force and a network of distributors. Founded in 1983 as Vascutech, Inc., the company rebranded as LeMaitre Vascular, Inc. in April 2001.
It is headquartered in Burlington, Massachusetts.
based on 22.88M shares outstanding
30d Avg
309.48K
60d Avg
286.21K
90d Avg
296.31K